Navigation Links
Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer
Date:7/23/2014

SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the transcarotid treatment of intra- and extra-cranial cerebrovascular disease, announced today the appointment of Michael P. Wallace to the position of Chief Technology Officer.  In this new role, Michael will lead the company's Research and Development efforts across its family of transcarotid access and treatment devices.

Prior to joining Silk Road Medical, Michael was the Vice President of Research and Development at Boston Scientific's Electrophysiology Division and previously held senior technical leadership roles at Baxano Surgical, Inc., BARRx Medical, and Boston Scientific Neurovascular / Target Therapeutics. He has over 20 years of experience in the medical device field and holds over 120 issued or pending US patents.

"The addition of Mike Wallace completes the all-star executive line up at Silk Road.  Our executives are deeply experienced in the fields of carotid and neurovascular diseases and are considered the best in the industry across marketing, clinical, operations, and R&D. Our impressive executive team and the recently announced completion of enrollment in our pivotal ROADSTER Trial positions Silk Road Medical for the promising future of transcarotid interventions," said Erica Rogers, President and Chief Executive Officer.

"I am thrilled to join Silk Road to lead the R&D team through the commercial development of its pioneering and unique ENROUTE™ Transcarotid Neuroprotection and Stent Systems for treating blockages in the artery of the neck.  Despite decades of development, traditional transfemoral carotid stenting (CAS) has been associated with an excess risk of stroke due to aortic arch catheterization and less than ideal embolic protection devices.  With Silk Road's surgically-inspired approach, we believe we can reduce the risk of stroke on par with the gold standard of carotid endarterectomy (CEA) while preserving the benefits of a less invasive stenting procedure," said Mike. "Looking forward, I am also equally excited about the opportunity to help patients with neurovascular diseases by developing a suite of products that highlights the surgeon control and procedure time advantages we believe are possible with our transcarotid access point."

About the ENROUTE Transcarotid Neuroprotection and Stent Systems

The Silk Road procedure includes a combination direct carotid access sheath and dynamic flow reversal circuit, and a carotid stent. After a tiny incision is made at the neckline, the physician inserts a small tube, called a sheath, into the carotid artery.  The sheath is connected to a device that temporarily re-directs blood flow away from the brain.  Reversing the blood flow allows a physician to place a stent inside the blockage without risk of plaque breaking off and traveling up toward the brain.  After the stent is placed successfully, flow reversal is turned off and blood flow resumes in its normal direction.  Typically, the Silk Road procedure is performed under local anesthesia and can significantly minimize recovery time and scarring for the patient.  

About Silk Road Medical, Inc.

Silk Road Medical, Inc. is a private company located in Sunnyvale, CA, that develops and manufactures minimally-invasive medical devices intended to improve the treatment of intra- and extra-cranial cerebrovascular disease through proprietary transcarotid access and treatment platforms.  Detailed information about Silk Road Medical can be found at www.silkroadmed.com.

Both the ENROUTE Transcarotid NPS and Stent System have been granted CE Mark. The ENROUTE NPS is limited by United States law to investigational use. The ENROUTE Transcarotid Stent System is not currently available in the United States.


'/>"/>
SOURCE Silk Road Medical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report
2. Edwards CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
3. Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices
4. American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment
5. EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner
6. MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center
7. Dr. Ryan Diederich appointed to Illinois State Medical Society Council
8. Apex Medicals Respiratory Therapy Product Receives Affirmation from USITC
9. ViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
10. DICOM Grid Secures $6 Million to Meet Growing Demand for Digital Medical Imaging in the Cloud
11. Sutter Medical Center, Sacramento Pioneers Most-Advanced Surgical Robot in California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 Research and Markets has announced the addition ... report to their offering. ... The report also analyses the market by the following Technology Types: ... for the US, Canada , Japan ... Latin America , and Rest of World. ...
(Date:12/9/2016)... 9, 2016 aTyr Pharma, Inc. (Nasdaq: LIFE ... Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior ... Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in ... 2016, at 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma ...
(Date:12/9/2016)... 2016  Forge Therapeutics, Inc. today announced a ... EVT, TecDAX, ISIN: DE0005664809) to advance its novel ... of bacterial infections including those caused by drug ... attractive antibacterial target for more than the past ... starting points has hampered its progress. Forge has ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing ... grand opening of the Sober College Robert Pfeifer Memorial Learning Center at its ... and was attended by an overwhelming amount of alumni, family, colleagues and friends ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time ... Winchester, Va. "I thought that if the nebulizer had a more child-friendly design, then ... them." , He developed the patent-pending NEBY to avoid the need to deliver medication ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
Breaking Medicine News(10 mins):